Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Importation from Canada dropping

Executive Summary

According to Health Canada, there has been a substantial and steady decline in cross-border drug sales since the beginning of 2006 - a trend that could temper support for importation legislation, which will likely be considered in the Democrat-led Congress (1"The Pink Sheet" Nov. 13, 2006, p. 3). In light of possible action and a recent U.S. law allowing personal importation, groups representing Canadian pharmacists, patients and distributors recently requested an immediate ban on bulk and retail drug exports. Health Canada says such a ban would be "premature" and that it sees no evidence to suggest individual importation poses an imminent threat to the Canadian drug supply...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS047807

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel